Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Seffer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Toxins|January 24, 2025
Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?Marie-Lise Gougeon, Valérie Seffer, Cezarela Hoxha, et al.
Frontiers in Immunology|November 16, 2020
Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) SignalingSandra Bos, Béatrice Poirier-Beaudouin, Valérie Seffer, et al.
Plos One|April 3, 2014
Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cellsEmily Loison, Béatrice Poirier-Beaudouin, Valérie Seffer, et al.
Toxins|February 26, 2026
<i>Clostridioides difficile</i> Immunity During Pregnancy and Passive Antibody Transfer to Neonates from Cord Blood and Breast MilkAlban Le Monnier, Claire de Curraize, Valérie Seffer, et al.
Vaccine|September 30, 2017
CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measlesCatherine Goujon, Marie-Lise Gougeon, Laura Tondeur, et al.
Plos Pathogens|April 22, 2026
Modeling neonatal immune response to B. pertussis identifies early B cell activation and differentiationSoraya Matczak, Mirko Sadi, Pauline Leroux, et al.
Heliyon|February 23, 2017
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND)Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Heliyon|April 4, 2017
Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Toxins|January 24, 2025
Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?Marie-Lise Gougeon, Valérie Seffer, Cezarela Hoxha, et al.
Frontiers in Immunology|November 16, 2020
Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) SignalingSandra Bos, Béatrice Poirier-Beaudouin, Valérie Seffer, et al.
Plos One|April 3, 2014
Suppression by thimerosal of ex-vivo CD4+ T cell response to influenza vaccine and induction of apoptosis in primary memory T cellsEmily Loison, Béatrice Poirier-Beaudouin, Valérie Seffer, et al.
Toxins|February 26, 2026
<i>Clostridioides difficile</i> Immunity During Pregnancy and Passive Antibody Transfer to Neonates from Cord Blood and Breast MilkAlban Le Monnier, Claire de Curraize, Valérie Seffer, et al.
Vaccine|September 30, 2017
CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measlesCatherine Goujon, Marie-Lise Gougeon, Laura Tondeur, et al.
Plos Pathogens|April 22, 2026
Modeling neonatal immune response to B. pertussis identifies early B cell activation and differentiationSoraya Matczak, Mirko Sadi, Pauline Leroux, et al.
Heliyon|February 23, 2017
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND)Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Heliyon|April 4, 2017
Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'Marie-Lise Gougeon, Béatrice Poirier-Beaudouin, Jacques Durant, et al.
Vaccine|January 13, 2009
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trialOdile Launay, Christine Sadorge, Nathalie Jolly, et al.
Pageof 1